CClinicalTrials.gg
Status unknownNCT03738371OPTISSUpdated Nov 13, 2018

Formation of Health Professionals Through in Situ Simulation to Improve Performances During the Initial Step of Thrombectomy for Ischemic Strokes

An observational study in Time, Benefit of in Situ Simulation for This Kind of Training and Installation of the Patient Until the Percutaneous, sponsored by Hospices Civils de Lyon. Status unknown at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-13.

Sponsored by Hospices Civils de Lyon · Observational

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

The thrombectomy is an emergency care provided as soon as possible to selected patients suffering from ischemic strokes. Many steps are necessary to prepare this specialized procedure of interventional neuroradiology, including installation and preparation of the patient for this act. This first and essential time required the intervention of many health professionals.

The approach consists of a series of formation through in situ simulations for these health professionals, in order to improve and optimize this first step of the procedure (from the installation of the patient to the percutaneous punch by the neuroradiologist).

02

Conditions studied

  • Time
  • Benefit of in Situ Simulation for This Kind of Training
  • Installation of the Patient Until the Percutaneous
03

In context

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

health professionals

Eligibility criteria

Inclusion Criteria:

  • voluntary professionals
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Team of health professionals

    Team of health professionals involved in thrombectomy (including specialized nurses in anesthesiology, anesthesiologists, neuroradiologist and technicians specialized in electro-radiology) will participate to in situ simulation.

    Other: In situ simulation

Interventions

  • OtherIn situ simulation

    Team involved in thrombectomy procedures will be trained by in situ simulation. Simulation will reproduce the initial step of a thrombectomy procedure, i.e from from the installation of the patient to the percutaneous punch by the neuroradiologist. Simulation will be followed by a debriefing focused on the team performance. Three in situ simulation sessions will be realized by each team.

06

What researchers measure

Primary outcomes

  1. Performance of the team

    Performance of the team will be scored using a technical and non-technical skill.

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Hôpital neurologique, Centre Hospitalier Universitaire
    Lyon, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03738371
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Nov 13, 2018
Start date
Oct 1, 2018
Primary completion
Oct 1, 2018
Completion
Dec 1, 2019 (estimated)
Last update
Nov 13, 2018

Study contacts

Lionel BAPTESTE, MD
Contact
lionel.bapteste@chu-lyon.fr
0472357944 ext. +33
Lionel BAPTESTE, MD
principal investigator · Hospices Civils de Lyon

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion